Pre‐transplant immune cell function assay as a predictor of early cardiac allograft rejection

ImmuKnow, an immune cell function assay that quantifies overall immune system activity can assist in post‐transplant immunosuppression adjustment. However, the utility of pre‐transplant ImmuKnow results representing a patient's baseline immune system activity is unknown. This study sought to assess if pre‐transplant ImmuKnow results are predictive of rejection at the time of first biopsy in our cardiac transplant population.